Dopamine d3 receptor ser9gly polymorphism and risperidone response / Hsien Yuan Lane en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 6-11 Título : Dopamine d3 receptor ser9gly polymorphism and risperidone response Tipo de documento: texto impreso Autores: Hsien Yuan Lane, Autor ; Shih-Kuan Hsu, Autor ; Yi-Ching Liu, Autor Fecha de publicación: 2023 Artículo en la página: pp. 6-11 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, ADN - genética, Polimorfismo, Genética, Receptores de Dopamina D2, Risperidona, Esquizofrenia, Comportamiento social Resumen: Risperidone is an atypical antipsychotic agent with efficacy for both positive and negative symptoms of schizophrenia. Risperidone is a potent dopamine D3 antagonist and agonism at D3 sites induces behavioral suppression in rodents. We thus hypothesized that D3 antagonism may contribute to response to risperidone in negative symptoms. Link: ./index.php?lvl=notice_display&id=30920 [artículo] Dopamine d3 receptor ser9gly polymorphism and risperidone response [texto impreso] / Hsien Yuan Lane, Autor ; Shih-Kuan Hsu, Autor ; Yi-Ching Liu, Autor . - 2023 . - pp. 6-11. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 6-11 Palabras clave: Antipsicóticos, ADN - genética, Polimorfismo, Genética, Receptores de Dopamina D2, Risperidona, Esquizofrenia, Comportamiento social Resumen: Risperidone is an atypical antipsychotic agent with efficacy for both positive and negative symptoms of schizophrenia. Risperidone is a potent dopamine D3 antagonist and agonism at D3 sites induces behavioral suppression in rodents. We thus hypothesized that D3 antagonism may contribute to response to risperidone in negative symptoms. Link: ./index.php?lvl=notice_display&id=30920

Early prediction of fluoxetine response for han chinese inpatients with major depressive disorder / Ching Hua Lin en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 2 (Abril) . - pp. 187-193 Título : Early prediction of fluoxetine response for han chinese inpatients with major depressive disorder Tipo de documento: texto impreso Autores: Ching Hua Lin, Autor ; Hsien Yuan Lane, Autor ; Cheng Chung Chen, Autor Fecha de publicación: 2022 Artículo en la página: pp. 187-193 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno depresivo mayor, Fluoxetina, Modelo de predicción temprana Resumen: The onset of antidepressant action is vital clinically. This study aimed to testify whether early symptom improvement can predict eventual treatment response at week 6 among depressive hospitalized patients taking fluoxetine. One hundred thirty-one hospitalized patients with major depressive disorder received 20 mg/d of fluoxetine for 6 weeks. Link: ./index.php?lvl=notice_display&id=29395 [artículo] Early prediction of fluoxetine response for han chinese inpatients with major depressive disorder [texto impreso] / Ching Hua Lin, Autor ; Hsien Yuan Lane, Autor ; Cheng Chung Chen, Autor . - 2022 . - pp. 187-193. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 2 (Abril) . - pp. 187-193 Palabras clave: Trastorno depresivo mayor, Fluoxetina, Modelo de predicción temprana Resumen: The onset of antidepressant action is vital clinically. This study aimed to testify whether early symptom improvement can predict eventual treatment response at week 6 among depressive hospitalized patients taking fluoxetine. One hundred thirty-one hospitalized patients with major depressive disorder received 20 mg/d of fluoxetine for 6 weeks. Link: ./index.php?lvl=notice_display&id=29395

Influences of patient-related variables on risperidone efficacy for acutely exacerbated schizophrenia: analyses with rigorous statistics / Hsien Yuan Lane en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 4 (Agosto)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 4 (Agosto) . - pp. 353-358 Título : Influences of patient-related variables on risperidone efficacy for acutely exacerbated schizophrenia: analyses with rigorous statistics Tipo de documento: texto impreso Autores: Hsien Yuan Lane, Autor ; Yue Cune Chang, Autor ; Chi Chiang Chiu, Autor Fecha de publicación: 2023 Artículo en la página: pp. 353-358 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Hospitalización, Pacientes, Risperidona, Esquizofrenia Resumen: Response predictors of risperidone or other newer atypical antipsychotics for schizophrenia treatment remain unclear. This study aimed to investigate the influence of patient demographics on risperidone efficacy for schizophrenia. One hundred twenty-one newly hospitalized patients who had schizophrenia with acute exacerbation entered this prospective, 6-week risperidone trial. Link: ./index.php?lvl=notice_display&id=31050 [artículo] Influences of patient-related variables on risperidone efficacy for acutely exacerbated schizophrenia: analyses with rigorous statistics [texto impreso] / Hsien Yuan Lane, Autor ; Yue Cune Chang, Autor ; Chi Chiang Chiu, Autor . - 2023 . - pp. 353-358. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 4 (Agosto) . - pp. 353-358 Palabras clave: Antipsicóticos, Hospitalización, Pacientes, Risperidona, Esquizofrenia Resumen: Response predictors of risperidone or other newer atypical antipsychotics for schizophrenia treatment remain unclear. This study aimed to investigate the influence of patient demographics on risperidone efficacy for schizophrenia. One hundred twenty-one newly hospitalized patients who had schizophrenia with acute exacerbation entered this prospective, 6-week risperidone trial. Link: ./index.php?lvl=notice_display&id=31050

Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effects / Hsien Yuan Lane en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Febrero) . - pp. 4-10 Título : Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effects Tipo de documento: texto impreso Autores: Hsien Yuan Lane, Autor ; Yue Cune Chang, Autor ; Muh-Hwan Su, Autor Fecha de publicación: 2023 Artículo en la página: pp. 4-10 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Enfermedad de Alzheimer, Antipsicóticos, Demencia Vascular, Haloperidol, Pruebas neuropsicológicas, Agitación psicomotora, Risperidona, Trastornos de la conducta social Resumen: For agitated dementia showing insufficient response to conventional antipsychotics, the feasibility of transition to atypical agents remains unknown. Sixty-two Chinese inpatients with dementia and disruptive behaviors were recruited into an 8-week screening trial of haloperidol. Thirty-five (56%) of them responded insufficiently. Link: ./index.php?lvl=notice_display&id=31087 [artículo] Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effects [texto impreso] / Hsien Yuan Lane, Autor ; Yue Cune Chang, Autor ; Muh-Hwan Su, Autor . - 2023 . - pp. 4-10. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Febrero) . - pp. 4-10 Palabras clave: Enfermedad de Alzheimer, Antipsicóticos, Demencia Vascular, Haloperidol, Pruebas neuropsicológicas, Agitación psicomotora, Risperidona, Trastornos de la conducta social Resumen: For agitated dementia showing insufficient response to conventional antipsychotics, the feasibility of transition to atypical agents remains unknown. Sixty-two Chinese inpatients with dementia and disruptive behaviors were recruited into an 8-week screening trial of haloperidol. Thirty-five (56%) of them responded insufficiently. Link: ./index.php?lvl=notice_display&id=31087

---

1 (1 - 4 / 4)